| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥24.12 |
| 52 Week High | CN¥44.00 |
| 52 Week Low | CN¥20.91 |
| Beta | 0.60 |
| 1 Month Change | -0.45% |
| 3 Month Change | 7.58% |
| 1 Year Change | -35.25% |
| 3 Year Change | 43.83% |
| 5 Year Change | 11.26% |
| Change since IPO | 3,250.65% |
Recent News & Updates
Shareholder Returns
| 600771 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.2% | 0.8% | -0.4% |
| 1Y | -35.2% | -13.4% | -14.4% |
Return vs Industry: 600771 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 600771 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 600771 volatility | |
|---|---|
| 600771 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600771 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600771's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,950 | n/a | www.guangyuyuan.com |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional and fine Chinese medicines, as well as health wines.
GuangYuYuan Chinese Herbal Medicine Co., Ltd. Fundamentals Summary
| 600771 fundamental statistics | |
|---|---|
| Market cap | CN¥11.81b |
| Earnings (TTM) | -CN¥324.42m |
| Revenue (TTM) | CN¥1.11b |
10.6x
P/S Ratio-36.4x
P/E RatioIs 600771 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600771 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.11b |
| Cost of Revenue | CN¥347.95m |
| Gross Profit | CN¥763.25m |
| Other Expenses | CN¥1.09b |
| Earnings | -CN¥324.42m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 68.69% |
| Net Profit Margin | -29.20% |
| Debt/Equity Ratio | 14.1% |
How did 600771 perform over the long term?
See historical performance and comparison